Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|June 1, 2000
Changes in ADC caused by tensile loading of rabbit achilles tendon: evidence for water transportS Han, S J Gemmell, K G Helmer, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 1, 1984
In vivo strain patterns in the four major canine knee ligamentsJ J Monahan, P Grigg, A M Pappas, et al.
Thrombosis and Haemostasis|May 13, 2019
Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory ResponseAbdullah Hamadi, Andrew P Grigg, Gasim Dobie, et al.
Cancer|September 17, 2004
A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignanciesConstantine S Tam, Max M Wolf, E Henry Januszewicz, et al.
Journal of Texture Studies|August 3, 2017
The slip extrusion test: A novel method to characterise bolus propertiesG C F Ng, E M Gray-Stuart, M P Morgenstern, et al.
Haematologica|June 1, 2005
Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignanciesConstantine Tam, John F Seymour, Michael Brown, et al.
Australian and New Zealand Journal of Medicine|June 5, 1998
Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: a single institution retrospective studyD M Thomas, J F Seymour, J Szer, et al.
Bone Marrow Transplantation|May 1, 2007
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantationM A Slavin, A P Grigg, A P Schwarer, et al.
Blood|December 15, 1995
Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteersA P Grigg, A W Roberts, H Raunow, et al.
Annals of Hematology|November 8, 2006
The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphomaD S Ritchie, J F Seymour, A P Grigg, et al.
Pageof 16